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Acute hypoxemia is common in hospitalized patients as the 
result of acute and/or chronic diseases that may involve 
different tissues and organs. Regardless of etiology, generous 
oxygen supplementation is normally used in hypoxemic 
patients as the first-line supportive therapy without 
considering the potential negative effects of exposure to 
high oxygen concentrations in inspired gases (FiO2). A 
recent observational trial showed that health care personnel 
of the intensive care units is generally focused only on 
hypoxia: lower limits of peripheral oxygen saturation (SpO2) 
are extensively prescribed whereas upper limits are rarely 
considered (1). Therefore, a large proportion of critically 
ill patients is frequently exposed to unnecessary prolonged 
periods of hyperoxemia (2,3). A recent prospective study 
showed that in ED the use of an initial FiO2 at 0.4 rather 
than 0.6 was able to restore normoxia in almost all the 
hypoxemic patients and that two-third of them became 
hyperoxic even with 0.4 FiO2 (4).
The oxidative stress induced by hyperoxia on pulmonary, 
cardiovascular, and neurological systems have been 
demonstrated in several in vitro, animal and human studies. 
Hyperoxic acute lung injury is the most known form of 
oxygen-related toxicity but many other organs and systems 
may be impaired. In fact, sustained hyperoxia exerts 
detrimental effects at the cellular level, particularly in the 
mitochondria that usually plays a key role in detoxifying 
cells from reactive oxygen species (ROS). High amounts 
of oxygen are hard to handle by the mitochondria and 
may lead to an imbalance between pro- and anti-oxidant 
molecules with significant damages to cell components 
leading to activation of apoptotic pathways, loss of cellular 
homeostasis and cell death (5). Moreover, oxidative stress 
may induce the formation of reactive nitrogen species and 
the decrease of nitric oxide production with significant 
alteration in microcirculation and tissue perfusion. 
For the above reasons, oxygen should be considered a 
powerful drug requiring careful management to avoid under 
or overdosing and titration of oxygen therapy is strongly 
recommended, particularly in the emergency department 
(ED) and in the intensive care unit (ICU) (6). As expected by 
considering the pathobiology mechanisms, a retrospective 
cohort study demonstrated a U-shape relationship between 
PaO2 levels and hospital mortality in patients admitted to 
ICU (7), suggesting that both ipo- and hyperoxemia may 
cause an increased risk of mortality compared to normoxia. 
Normoxia is commonly defined as a PaO2 value ranging 
from 60 to 100 mmHg and different criteria have been 
used in clinical studies to define hyperoxemia leading to 
heterogeneous results difficult to compare. A recent cohort 
study showed that the relationship between PaO2 levels and 
patients’ outcome depend on the different metrics applied, 
with metrics of central tendencies (e.g., mean and median 
PaO2) showing the strongest correlation with outcome. 
Although results were more consistent in patients with 
PaO2 >200 mmHg, a linear relationship was also observed 
between the extent of hyperoxemia exposure and mortality 
even for lower levels of PaO2 (8). 
Due to the large use of oxygen therapy in emergency 
conditions, the main body of literature on the effects of 
hyperoxia refers to critically ill patients as for instance 
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patients with cardiac arrest, myocardial infarction, 
mechanical ventilation, sepsis, traumatic brain injury and 
stroke. Oxygen supplementation is currently administered 
in patients with acute coronary syndrome, regardless on 
SpO2 values, and it is a milestone in therapeutic algorithms 
in case of acute myocardial infarction. Similarly, oxygen 
therapy at high FiO2 is routinely used both in in-hospital 
and out-of-hospital cardiac arrest in accordance with 
the current American Heart Association guidelines that 
recommend using FiO2 of 100% during cardiopulmonary 
resuscitation in order to maximize the l ikelihood 
of achieving return of spontaneous circulation (9). 
Nevertheless, it should be recalled that many studies 
suggest that unnecessary exposure to O2 therapy can 
worsen the size of myocardial ischemia (10,11) and the 
ischemia-reperfusion brain injury with poor neurological 
outcome after cardiac arrest (12,13). Due to the common 
beliefs and the behavior of healthcare staff, mechanically 
ventilated patients are at risk to be exposed to significant 
period of useless hyperoxia during ICU stay (2). In 
this setting, several recent studies indicate that mild 
hyperoxemia seems to increase the mortality risk, 
mainly in sickest patients with respiratory dysfunction 
and sepsis (14-17). The effects of oxygen conservative 
strategies compared to more liberal strategies in ICU 
patients will be clarified soon by numerous ongoing large 
randomized controlled trials (ACTRN12615000957594, 
N C T 0 2 3 7 8 5 4 5 ,  N C T 0 3 1 7 4 0 0 2 ,  E U D R A C T 
201800252535). In patients with stroke and traumatic 
brain injury the use oxygen supplementation remains still 
controversial because of low number of trials and high 
inconsistency between each other (18,19). To sum up the 
data available on critically ill patients, a recent study meta-
analyzed the results of 25 randomized controlled trials on 
16,037 patients and concluded that oxygen therapy might 
become potentially harmful when targeted to SpO2 values 
above 96% with recommendation for a conservative use of 
oxygen therapy (20). 
Although adverse effects caused by un-needed oxygen 
therapy are expected to be similar to those observed 
in critically ill patients, differences in clinical and 
pathophysiological context and in time and level of exposure 
between intensive and non-intensive units may mitigate the 
negative impact of hyperoxia in patients admitted to general 
wards. Unfortunately, few data are available on the use of 
oxygen therapy and on its effects in patients admitted to 
non-intensive wards. This gap has been partially closed by 
a recent observational study aimed to investigate potential 
harmful effects of hyperoxaemia in non-critically ill patients 
who receive oxygen-therapy in non-invasive way (21). 
This single center South-Korean clinical experience 
retrospectively evaluated the relationship between early 
hyperoxaemia (i.e., first 3 days after ED admission) 
and patients’ outcome in 10,141 consecutive patients 
admitted to general wards after ED visit with at least 
two arterial blood gas analysis in the first 72 hours after 
admission. Noteworthy, hypoxemic patients (maximum 
PaO2 <60 mmHg) were excluded from the study in 
order to assess only the difference between hyperoxemia 
and normoxemia. Even patients who died or showed 
complications (i .e. ,  ICU transfer and respiratory, 
cardiovascular, hepatic, renal and coagulation dysfunction) 
in the first 5 days after hospital admission were excluded 
(18% of enrolled patients) to avoid confounding factors in 
the evaluation of delayed effects of hyperoxia. Indeed, this 
exclusion hindered the assessment of the possible short-
term negative effects of hyperoxia described in animal 
models, healthy volunteers and in critically ill patients, 
mainly with the use of very high FiO2 (22,23). In the study 
by Jeong et al. (21), the oxygenation state was evaluated 
using different PaO2 metrics as for instance maximum, 
median, average and area under the curve (AUC) of the 
first 72 hours from ED arrival and for each variable the 
upper quintile was compared to the others. Unadjusted and 
adjusted analysis showed that exposure to hyperoxemia in 
the first 3 days after hospital admission seems to increase 
90-day mortality, ICU admission and occurrence of organ 
dysfunctions after five days from the hospital admission. As 
expected, the authors noted that the total oxygen exposure 
measured by PaO2 AUC-72h, rather than maximum PaO2, 
was significantly related to outcome. Interestingly, data also 
suggest a possible association among hyperoxemia, liver and 
cardiovascular dysfunctions, already reported in critically ill 
patients (15), as well as the potential negative effects of high 
PaO2 exposure on haemostasis. 
Although observational and retrospective, and with 
some limitations in patient selection and definition of 
hyperoxemia, the study by Jeong et al. provides considerable 
new information on the effects of hyperoxemia in patients 
without significant critical illness admitted to general 
wards (21). The data confirm the findings observed in 
critically ill patients of harmful effects induced by non-
appropriate and overdosed O2 therapy even for short 
exposure. As occurred in the last years in ICU and ED, 
general wards healthcare staff should reconsider the 
management strategy of O2 therapy by using specific 
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protocols to prevent hypoxia as well as (mild) hyperoxia 
with pre-defined O2 doses based on the careful monitoring 
of SpO2. Further high-quality studies are needed to 
definitively confirm data observed in patients admitted 
to general wards, but in the mean time we strongly 
recommend to handle O2 with care.
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